293 related articles for article (PubMed ID: 10504797)
1. 18-Fluorodeoxyglucose imaging in oncology.
Harolds JA
J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
3. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
[TBL] [Abstract][Full Text] [Related]
4. Clinical role of positron emission tomography in oncology.
Bomanji JB; Costa DC; Ell PJ
Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
[TBL] [Abstract][Full Text] [Related]
5. Imaging: staging and evaluation of lymphoma using nuclear medicine.
Divgi C
Semin Oncol; 2005 Feb; 32(1 Suppl 1):S11-8. PubMed ID: 15786021
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging in evaluation of cancer patients.
Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
8. [Present status of PET images: clinical FDG PET in oncology].
Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of 18F-FDG detection with a dual-head coincidence camera: a review.
Ak I; Blokland JA; Pauwels EK; Stokkel MP
Eur J Nucl Med; 2001 Jun; 28(6):763-78. PubMed ID: 11440038
[TBL] [Abstract][Full Text] [Related]
11. The role of hybrid cameras in oncology.
Delbeke D; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):268-80. PubMed ID: 11105928
[TBL] [Abstract][Full Text] [Related]
12. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
13. Oncologic
Montilla-Soler JL; Makanji RJ; Barron BJ
Am J Med; 2018 Apr; 131(4):357-364. PubMed ID: 29274757
[TBL] [Abstract][Full Text] [Related]
14. Proposition: positron imaging with SPECT and dual-head scintillation cameras obviates the need for PET in oncologic imaging.
Madsen MT; Harkness BA
Med Phys; 1998 Nov; 25(11):2116-8. PubMed ID: 9829235
[No Abstract] [Full Text] [Related]
15. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
[TBL] [Abstract][Full Text] [Related]
16. [Positron-emission tomography in oncology].
Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F
Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer].
Demura Y; Mizuno S; Wakabayashi M; Totani Y; Okamura S; Ameshima S; Ishizaki T; Miyamori I; Ito H; Yonekura Y
Nihon Kokyuki Gakkai Zasshi; 2000 Sep; 38(9):676-81. PubMed ID: 11109804
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of FDG-PET in oncology.
Czernin J
Acta Med Austriaca; 2002; 29(5):162-70. PubMed ID: 12506767
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
Czech N; Brenner W; Kampen WU; Henze E
Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
[No Abstract] [Full Text] [Related]
[Next] [New Search]
